Diabetes and COVID-19: Ten Questions
The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only m...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-06-01
|
Series: | Advanced Journal of Emergency Medicine |
Subjects: | |
Online Access: | http://ajem.tums.ac.ir/index.php/ajem/article/view/442 |
id |
doaj-810665129f05478d9ef3ff0cbe3a6697 |
---|---|
record_format |
Article |
spelling |
doaj-810665129f05478d9ef3ff0cbe3a66972020-11-25T02:58:51ZengTehran University of Medical SciencesAdvanced Journal of Emergency Medicine2588-400X2020-06-0110.22114/ajem.v0i0.442Diabetes and COVID-19: Ten QuestionsMahbube Ebrahimpur0Moloud Payab1Mahnaz Pejman Sani2Bagher Larijani3Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IranObesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, IranDepartment of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only more likely than the general population to have COVID-19 but also they are among those high-risk categories that can have serious illness if they get the virus. http://ajem.tums.ac.ir/index.php/ajem/article/view/442Clinical ManagementCOVID-19DiabetesPathogenesisSARS-CoV-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mahbube Ebrahimpur Moloud Payab Mahnaz Pejman Sani Bagher Larijani |
spellingShingle |
Mahbube Ebrahimpur Moloud Payab Mahnaz Pejman Sani Bagher Larijani Diabetes and COVID-19: Ten Questions Advanced Journal of Emergency Medicine Clinical Management COVID-19 Diabetes Pathogenesis SARS-CoV-2 |
author_facet |
Mahbube Ebrahimpur Moloud Payab Mahnaz Pejman Sani Bagher Larijani |
author_sort |
Mahbube Ebrahimpur |
title |
Diabetes and COVID-19: Ten Questions |
title_short |
Diabetes and COVID-19: Ten Questions |
title_full |
Diabetes and COVID-19: Ten Questions |
title_fullStr |
Diabetes and COVID-19: Ten Questions |
title_full_unstemmed |
Diabetes and COVID-19: Ten Questions |
title_sort |
diabetes and covid-19: ten questions |
publisher |
Tehran University of Medical Sciences |
series |
Advanced Journal of Emergency Medicine |
issn |
2588-400X |
publishDate |
2020-06-01 |
description |
The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only more likely than the general population to have COVID-19 but also they are among those high-risk categories that can have serious illness if they get the virus.
|
topic |
Clinical Management COVID-19 Diabetes Pathogenesis SARS-CoV-2 |
url |
http://ajem.tums.ac.ir/index.php/ajem/article/view/442 |
work_keys_str_mv |
AT mahbubeebrahimpur diabetesandcovid19tenquestions AT moloudpayab diabetesandcovid19tenquestions AT mahnazpejmansani diabetesandcovid19tenquestions AT bagherlarijani diabetesandcovid19tenquestions |
_version_ |
1724704801128710144 |